APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insomnia Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Insomnia Medication Market Analysis and Forecast 2026-2032

Report ID 174003440227 December 2025209 pages

Choose your research edition.

Industry ResearchInsomnia Medication Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Insomnia Medication Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Insomnia Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insomnia Medication Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Insomnia Medication Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Insomnia Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Insomnia Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Insomnia Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Insomnia Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Insomnia Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Insomnia Medication include Takeda, Eisai, Sanofi, Johnson & Johnson, Merck, Pfizer, Vanda Pharmaceuticals, Somnus Therapeutics and SkyePharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Insomnia Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Insomnia Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Insomnia Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insomnia Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Insomnia Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Insomnia Medication sales, projected growth trends, production technology, application and end-user industry.

Insomnia Medication Segment by Company

Takeda

Eisai

Sanofi

Johnson & Johnson

Merck

Pfizer

Vanda Pharmaceuticals

Somnus Therapeutics

SkyePharma

Purdue Pharma

Pernix Therapeutics

Paratek Pharmaceuticals

Neurim

Minerva Neurosciences

Meda

Flynn Pharma

ECR Pharmaceuticals (Valeant)

Dainippon Sumitomo

Astellas

Insomnia Medication Segment by Type

Benzodiazepine Receptor Agonists

Nonbenzodiazepine Receptor Agonists

The Selective Melatonin Receptor Agonist Ramelteon

Sedating Antidepressants

Insomnia Medication Segment by Application

Adults

Kids

Insomnia Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insomnia Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insomnia Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insomnia Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Insomnia Medication in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insomnia Medication sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Insomnia Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Benzodiazepine Receptor Agonists Major Manufacturers Table 3. Nonbenzodiazepine Receptor Agonists Major Manufacturers Table 4. The Selective Melatonin Receptor Agonist Ramelteon Major Manufacturers Table 5. Sedating Antidepressants Major Manufacturers Table 6. Global Insomnia Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adults Major Manufacturers Table 8. Kids Major Manufacturers Table 9. Insomnia Medication Industry Trends Table 10. Insomnia Medication Industry Drivers Table 11. Insomnia Medication Industry Opportunities and Challenges Table 12. Insomnia Medication Industry Restraints Table 13. Global Insomnia Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Insomnia Medication Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Insomnia Medication Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Insomnia Medication Revenue Market Share by Region (2021-2026) Table 17. Global Insomnia Medication Revenue Market Share by Region (2027-2032) Table 18. Global Insomnia Medication Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 19. Global Insomnia Medication Sales by Region (2021-2026) & (W Pcs) Table 20. Global Insomnia Medication Sales by Region (2027-2032) & (W Pcs) Table 21. Global Insomnia Medication Sales Market Share by Region (2021-2026) Table 22. Global Insomnia Medication Sales Market Share by Region (2027-2032) Table 23. Global Insomnia Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Insomnia Medication Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Insomnia Medication Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Insomnia Medication Sales Market Share by Manufacturers (2021-2026) Table 27. Global Insomnia Medication Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 28. Global Insomnia Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Insomnia Medication Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Insomnia Medication Manufacturers, Product Type & Application Table 31. Global Insomnia Medication Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Insomnia Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Insomnia Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Insomnia Medication Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Insomnia Medication Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Insomnia Medication Revenue Market Share by Type (2021-2026) Table 38. Global Insomnia Medication Revenue Market Share by Type (2027-2032) Table 39. Global Insomnia Medication Sales by Type 2021 VS 2025 VS 2032 (W Pcs) Table 40. Global Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 41. Global Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 42. Global Insomnia Medication Sales Market Share by Type (2021-2026) Table 43. Global Insomnia Medication Sales Market Share by Type (2027-2032) Table 44. Global Insomnia Medication Price by Type (2021-2026) & (US$/Pcs) Table 45. Global Insomnia Medication Price by Type (2027-2032) & (US$/Pcs) Table 46. Global Insomnia Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Insomnia Medication Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Insomnia Medication Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Insomnia Medication Revenue Market Share by Application (2021-2026) Table 50. Global Insomnia Medication Revenue Market Share by Application (2027-2032) Table 51. Global Insomnia Medication Sales by Application 2021 VS 2025 VS 2032 (W Pcs) Table 52. Global Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 53. Global Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 54. Global Insomnia Medication Sales Market Share by Application (2021-2026) Table 55. Global Insomnia Medication Sales Market Share by Application (2027-2032) Table 56. Global Insomnia Medication Price by Application (2021-2026) & (US$/Pcs) Table 57. Global Insomnia Medication Price by Application (2027-2032) & (US$/Pcs) Table 58. Takeda Company Information Table 59. Takeda Business Overview Table 60. Takeda Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 61. Takeda Insomnia Medication Product Portfolio Table 62. Takeda Recent Development Table 63. Eisai Company Information Table 64. Eisai Business Overview Table 65. Eisai Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 66. Eisai Insomnia Medication Product Portfolio Table 67. Eisai Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 71. Sanofi Insomnia Medication Product Portfolio Table 72. Sanofi Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Insomnia Medication Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 81. Merck Insomnia Medication Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 86. Pfizer Insomnia Medication Product Portfolio Table 87. Pfizer Recent Development Table 88. Vanda Pharmaceuticals Company Information Table 89. Vanda Pharmaceuticals Business Overview Table 90. Vanda Pharmaceuticals Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 91. Vanda Pharmaceuticals Insomnia Medication Product Portfolio Table 92. Vanda Pharmaceuticals Recent Development Table 93. Somnus Therapeutics Company Information Table 94. Somnus Therapeutics Business Overview Table 95. Somnus Therapeutics Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 96. Somnus Therapeutics Insomnia Medication Product Portfolio Table 97. Somnus Therapeutics Recent Development Table 98. SkyePharma Company Information Table 99. SkyePharma Business Overview Table 100. SkyePharma Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 101. SkyePharma Insomnia Medication Product Portfolio Table 102. SkyePharma Recent Development Table 103. Purdue Pharma Company Information Table 104. Purdue Pharma Business Overview Table 105. Purdue Pharma Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 106. Purdue Pharma Insomnia Medication Product Portfolio Table 107. Purdue Pharma Recent Development Table 108. Pernix Therapeutics Company Information Table 109. Pernix Therapeutics Business Overview Table 110. Pernix Therapeutics Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 111. Pernix Therapeutics Insomnia Medication Product Portfolio Table 112. Pernix Therapeutics Recent Development Table 113. Paratek Pharmaceuticals Company Information Table 114. Paratek Pharmaceuticals Business Overview Table 115. Paratek Pharmaceuticals Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 116. Paratek Pharmaceuticals Insomnia Medication Product Portfolio Table 117. Paratek Pharmaceuticals Recent Development Table 118. Neurim Company Information Table 119. Neurim Business Overview Table 120. Neurim Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 121. Neurim Insomnia Medication Product Portfolio Table 122. Neurim Recent Development Table 123. Minerva Neurosciences Company Information Table 124. Minerva Neurosciences Business Overview Table 125. Minerva Neurosciences Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 126. Minerva Neurosciences Insomnia Medication Product Portfolio Table 127. Minerva Neurosciences Recent Development Table 128. Meda Company Information Table 129. Meda Business Overview Table 130. Meda Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 131. Meda Insomnia Medication Product Portfolio Table 132. Meda Recent Development Table 133. Flynn Pharma Company Information Table 134. Flynn Pharma Business Overview Table 135. Flynn Pharma Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 136. Flynn Pharma Insomnia Medication Product Portfolio Table 137. Flynn Pharma Recent Development Table 138. ECR Pharmaceuticals (Valeant) Company Information Table 139. ECR Pharmaceuticals (Valeant) Business Overview Table 140. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 141. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio Table 142. ECR Pharmaceuticals (Valeant) Recent Development Table 143. Dainippon Sumitomo Company Information Table 144. Dainippon Sumitomo Business Overview Table 145. Dainippon Sumitomo Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 146. Dainippon Sumitomo Insomnia Medication Product Portfolio Table 147. Dainippon Sumitomo Recent Development Table 148. Astellas Company Information Table 149. Astellas Business Overview Table 150. Astellas Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 151. Astellas Insomnia Medication Product Portfolio Table 152. Astellas Recent Development Table 153. North America Insomnia Medication Revenue by Type (2021-2026) & (US$ Million) Table 154. North America Insomnia Medication Revenue by Type (2027-2032) & (US$ Million) Table 155. North America Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 156. North America Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 157. North America Insomnia Medication Sales Price by Type (2021-2026) & (US$/Pcs) Table 158. North America Insomnia Medication Sales Price by Type (2027-2032) & (US$/Pcs) Table 159. North America Insomnia Medication Revenue by Application (2021-2026) & (US$ Million) Table 160. North America Insomnia Medication Revenue by Application (2027-2032) & (US$ Million) Table 161. North America Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 162. North America Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 163. North America Insomnia Medication Sales Price by Application (2021-2026) & (US$/Pcs) Table 164. North America Insomnia Medication Sales Price by Application (2027-2032) & (US$/Pcs) Table 165. North America Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. North America Insomnia Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. North America Insomnia Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. North America Insomnia Medication Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 169. North America Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 170. North America Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 171. North America Insomnia Medication Sales Price by Country (2021-2026) & (US$/Pcs) Table 172. North America Insomnia Medication Sales Price by Country (2027-2032) & (US$/Pcs) Table 173. United States Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 174. Canada Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 175. Mexico Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 176. Europe Insomnia Medication Revenue by Type (2021-2026) & (US$ Million) Table 177. Europe Insomnia Medication Revenue by Type (2027-2032) & (US$ Million) Table 178. Europe Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 179. Europe Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 180. Europe Insomnia Medication Sales Price by Type (2021-2026) & (US$/Pcs) Table 181. Europe Insomnia Medication Sales Price by Type (2027-2032) & (US$/Pcs) Table 182. Europe Insomnia Medication Revenue by Application (2021-2026) & (US$ Million) Table 183. Europe Insomnia Medication Revenue by Application (2027-2032) & (US$ Million) Table 184. Europe Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 185. Europe Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 186. Europe Insomnia Medication Sales Price by Application (2021-2026) & (US$/Pcs) Table 187. Europe Insomnia Medication Sales Price by Application (2027-2032) & (US$/Pcs) Table 188. Europe Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Europe Insomnia Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Europe Insomnia Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Europe Insomnia Medication Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 192. Europe Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 193. Europe Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 194. Europe Insomnia Medication Sales Price by Country (2021-2026) & (US$/Pcs) Table 195. Europe Insomnia Medication Sales Price by Country (2027-2032) & (US$/Pcs) Table 196. Germany Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 197. France Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 198. U.K. Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 199. Italy Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 200. Russia Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 201. Spain Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 202. Netherlands Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 203. Switzerland Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 204. Sweden Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 205. Poland Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 206. China Insomnia Medication Revenue by Type (2021-2026) & (US$ Million) Table 207. China Insomnia Medication Revenue by Type (2027-2032) & (US$ Million) Table 208. China Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 209. China Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 210. China Insomnia Medication Sales Price by Type (2021-2026) & (US$/Pcs) Table 211. China Insomnia Medication Sales Price by Type (2027-2032) & (US$/Pcs) Table 212. China Insomnia Medication Revenue by Application (2021-2026) & (US$ Million) Table 213. China Insomnia Medication Revenue by Application (2027-2032) & (US$ Million) Table 214. China Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 215. China Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 216. China Insomnia Medication Sales Price by Application (2021-2026) & (US$/Pcs) Table 217. China Insomnia Medication Sales Price by Application (2027-2032) & (US$/Pcs) Table 218. Asia Insomnia Medication Revenue by Type (2021-2026) & (US$ Million) Table 219. Asia Insomnia Medication Revenue by Type (2027-2032) & (US$ Million) Table 220. Asia Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 221. Asia Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 222. Asia Insomnia Medication Sales Price by Type (2021-2026) & (US$/Pcs) Table 223. Asia Insomnia Medication Sales Price by Type (2027-2032) & (US$/Pcs) Table 224. Asia Insomnia Medication Revenue by Application (2021-2026) & (US$ Million) Table 225. Asia Insomnia Medication Revenue by Application (2027-2032) & (US$ Million) Table 226. Asia Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 227. Asia Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 228. Asia Insomnia Medication Sales Price by Application (2021-2026) & (US$/Pcs) Table 229. Asia Insomnia Medication Sales Price by Application (2027-2032) & (US$/Pcs) Table 230. Asia Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. Asia Insomnia Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. Asia Insomnia Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. Asia Insomnia Medication Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 234. Asia Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 235. Asia Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 236. Asia Insomnia Medication Sales Price by Country (2021-2026) & (US$/Pcs) Table 237. Asia Insomnia Medication Sales Price by Country (2027-2032) & (US$/Pcs) Table 238. Japan Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 239. South Korea Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 240. India Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 241. Australia Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 242. Taiwan Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 243. Southeast Asia Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 244. SAMEA Insomnia Medication Revenue by Type (2021-2026) & (US$ Million) Table 245. SAMEA Insomnia Medication Revenue by Type (2027-2032) & (US$ Million) Table 246. SAMEA Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 247. SAMEA Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 248. SAMEA Insomnia Medication Sales Price by Type (2021-2026) & (US$/Pcs) Table 249. SAMEA Insomnia Medication Sales Price by Type (2027-2032) & (US$/Pcs) Table 250. SAMEA Insomnia Medication Revenue by Application (2021-2026) & (US$ Million) Table 251. SAMEA Insomnia Medication Revenue by Application (2027-2032) & (US$ Million) Table 252. SAMEA Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 253. SAMEA Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 254. SAMEA Insomnia Medication Sales Price by Application (2021-2026) & (US$/Pcs) Table 255. SAMEA Insomnia Medication Sales Price by Application (2027-2032) & (US$/Pcs) Table 256. SAMEA Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. SAMEA Insomnia Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 258. SAMEA Insomnia Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 259. SAMEA Insomnia Medication Sales by Country (2021 VS 2025 VS 2032) & (W Pcs) Table 260. SAMEA Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 261. SAMEA Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 262. SAMEA Insomnia Medication Sales Price by Country (2021-2026) & (US$/Pcs) Table 263. SAMEA Insomnia Medication Sales Price by Country (2027-2032) & (US$/Pcs) Table 264. Brazil Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 265. Argentina Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 266. Chile Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 267. Colombia Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 268. Peru Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 269. Saudi Arabia Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 270. Israel Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 271. UAE Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 272. Turkey Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 273. Iran Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 274. Egypt Insomnia Medication Revenue (2021-2032) & (US$ Million) Table 275. Key Raw Materials Table 276. Raw Materials Key Suppliers Table 277. Insomnia Medication Distributors List Table 278. Insomnia Medication Customers List Table 279. Research Programs/Design for This Report Table 280. Authors List of This Report Table 281. Secondary Sources Table 282. Primary Sources List of Figures Figure 1. Insomnia Medication Image Figure 2. Global Insomnia Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insomnia Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Benzodiazepine Receptor Agonists Image Figure 5. Nonbenzodiazepine Receptor Agonists Image Figure 6. The Selective Melatonin Receptor Agonist Ramelteon Image Figure 7. Sedating Antidepressants Image Figure 8. Global Insomnia Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Insomnia Medication Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adults Image Figure 11. Kids Image Figure 12. Global Insomnia Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Insomnia Medication Revenue (2021-2032) & (US$ Million) Figure 14. Global Insomnia Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Insomnia Medication Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Insomnia Medication Revenue Market Share by Region (2021-2032) Figure 17. Global Insomnia Medication Sales (2021-2032) & (W Pcs) Figure 18. Global Insomnia Medication Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Figure 19. Global Insomnia Medication Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Insomnia Medication Sales YoY (2021-2032) & (W Pcs) Figure 21. Europe Insomnia Medication Sales YoY (2021-2032) & (W Pcs) Figure 22. China Insomnia Medication Sales YoY (2021-2032) & (W Pcs) Figure 23. Asia (Excluding China) Insomnia Medication Sales YoY (2021-2032) & (W Pcs) Figure 24. South America, Middle East and Africa Insomnia Medication Sales YoY (2021-2032) & (W Pcs) Figure 25. Global Insomnia Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Insomnia Medication Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Insomnia Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Insomnia Medication Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Insomnia Medication Revenue Market Share by Type (2021-2032) Figure 31. Global Insomnia Medication Sales by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 32. Global Insomnia Medication Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Insomnia Medication Sales Market Share by Type (2021-2032) Figure 34. Global Insomnia Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Insomnia Medication Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Insomnia Medication Revenue Market Share by Application (2021-2032) Figure 37. Global Insomnia Medication Sales by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 38. Global Insomnia Medication Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Insomnia Medication Sales Market Share by Application (2021-2032) Figure 40. North America Insomnia Medication Revenue Share by Type (2021-2032) Figure 41. North America Insomnia Medication Sales Share by Type (2021-2032) Figure 42. North America Insomnia Medication Revenue Share by Application (2021-2032) Figure 43. North America Insomnia Medication Sales Share by Application (2021-2032) Figure 44. North America Insomnia Medication Revenue Share by Country (2021-2032) Figure 45. North America Insomnia Medication Sales Share by Country (2021-2032) Figure 46. Europe Insomnia Medication Revenue Share by Type (2021-2032) Figure 47. Europe Insomnia Medication Sales Share by Type (2021-2032) Figure 48. Europe Insomnia Medication Revenue Share by Application (2021-2032) Figure 49. Europe Insomnia Medication Sales Share by Application (2021-2032) Figure 50. Europe Insomnia Medication Revenue Share by Country (2021-2032) Figure 51. Europe Insomnia Medication Sales Share by Country (2021-2032) Figure 52. China Insomnia Medication Revenue Share by Type (2021-2032) Figure 53. China Insomnia Medication Sales Share by Type (2021-2032) Figure 54. China Insomnia Medication Revenue Share by Application (2021-2032) Figure 55. China Insomnia Medication Sales Share by Application (2021-2032) Figure 56. Asia Insomnia Medication Revenue Share by Type (2021-2032) Figure 57. Asia Insomnia Medication Sales Share by Type (2021-2032) Figure 58. Asia Insomnia Medication Revenue Share by Application (2021-2032) Figure 59. Asia Insomnia Medication Sales Share by Application (2021-2032) Figure 60. Asia Insomnia Medication Revenue Share by Country (2021-2032) Figure 61. Asia Insomnia Medication Sales Share by Country (2021-2032) Figure 62. SAMEA Insomnia Medication Revenue Share by Type (2021-2032) Figure 63. SAMEA Insomnia Medication Sales Share by Type (2021-2032) Figure 64. SAMEA Insomnia Medication Revenue Share by Application (2021-2032) Figure 65. SAMEA Insomnia Medication Sales Share by Application (2021-2032) Figure 66. SAMEA Insomnia Medication Revenue Share by Country (2021-2032) Figure 67. SAMEA Insomnia Medication Sales Share by Country (2021-2032) Figure 68. Insomnia Medication Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Insomnia Medication Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Benzodiazepine Receptor Agonists
  • Nonbenzodiazepine Receptor Agonists
  • The Selective Melatonin Receptor Agonist Ramelteon
  • Sedating Antidepressants
Applications
  • Adults
  • Kids
Companies covered
  • Takeda
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • Merck
  • Pfizer
  • Vanda Pharmaceuticals
  • Somnus Therapeutics
  • SkyePharma
  • Purdue Pharma
  • Pernix Therapeutics
  • Paratek Pharmaceuticals
  • Neurim
  • Minerva Neurosciences
  • Meda
  • Flynn Pharma
  • ECR Pharmaceuticals (Valeant)
  • Dainippon Sumitomo
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Insomnia Medication Market by Type
  3. 1.2.1 Global Insomnia Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Benzodiazepine Receptor Agonists
  5. 1.2.3 Nonbenzodiazepine Receptor Agonists
  6. 1.2.4 The Selective Melatonin Receptor Agonist Ramelteon
  7. 1.2.5 Sedating Antidepressants
  8. 1.3 Insomnia Medication Market by Application
  9. 1.3.1 Global Insomnia Medication Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adults
  11. 1.3.3 Kids
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Insomnia Medication Market Dynamics
  1. 2.1 Insomnia Medication Industry Trends
  2. 2.2 Insomnia Medication Industry Drivers
  3. 2.3 Insomnia Medication Industry Opportunities and Challenges
  4. 2.4 Insomnia Medication Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Insomnia Medication Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Insomnia Medication Revenue by Region
  3. 3.2.1 Global Insomnia Medication Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Insomnia Medication Revenue by Region (2021-2026)
  5. 3.2.3 Global Insomnia Medication Revenue by Region (2027-2032)
  6. 3.2.4 Global Insomnia Medication Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Insomnia Medication Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Insomnia Medication Sales by Region
  9. 3.4.1 Global Insomnia Medication Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Insomnia Medication Sales by Region (2021-2026)
  11. 3.4.3 Global Insomnia Medication Sales by Region (2027-2032)
  12. 3.4.4 Global Insomnia Medication Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Insomnia Medication Revenue by Manufacturers
  2. 4.1.1 Global Insomnia Medication Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Insomnia Medication Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Insomnia Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Insomnia Medication Sales by Manufacturers
  6. 4.2.1 Global Insomnia Medication Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Insomnia Medication Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Insomnia Medication Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Insomnia Medication Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Insomnia Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Insomnia Medication Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Insomnia Medication Manufacturers, Product Type & Application
  13. 4.7 Global Insomnia Medication Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Insomnia Medication Market CR5 and HHI
  16. 4.8.2 2025 Insomnia Medication Tier 1, Tier 2, and Tier 3
5 Insomnia Medication Market by Type
  1. 5.1 Global Insomnia Medication Revenue by Type
  2. 5.1.1 Global Insomnia Medication Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Insomnia Medication Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Insomnia Medication Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Insomnia Medication Sales by Type
  6. 5.2.1 Global Insomnia Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insomnia Medication Sales by Type (2021-2032) & (W Pcs)
  8. 5.2.3 Global Insomnia Medication Sales Market Share by Type (2021-2032)
  9. 5.3 Global Insomnia Medication Price by Type
6 Insomnia Medication Market by Application
  1. 6.1 Global Insomnia Medication Revenue by Application
  2. 6.1.1 Global Insomnia Medication Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Insomnia Medication Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Insomnia Medication Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Insomnia Medication Sales by Application
  6. 6.2.1 Global Insomnia Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Insomnia Medication Sales by Application (2021-2032) & (W Pcs)
  8. 6.2.3 Global Insomnia Medication Sales Market Share by Application (2021-2032)
  9. 6.3 Global Insomnia Medication Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Insomnia Medication Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Eisai
  8. 7.2.1 Eisai Company Information
  9. 7.2.2 Eisai Business Overview
  10. 7.2.3 Eisai Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Insomnia Medication Product Portfolio
  12. 7.2.5 Eisai Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Insomnia Medication Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Insomnia Medication Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Insomnia Medication Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Insomnia Medication Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Vanda Pharmaceuticals
  38. 7.7.1 Vanda Pharmaceuticals Company Information
  39. 7.7.2 Vanda Pharmaceuticals Business Overview
  40. 7.7.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vanda Pharmaceuticals Insomnia Medication Product Portfolio
  42. 7.7.5 Vanda Pharmaceuticals Recent Developments
  43. 7.8 Somnus Therapeutics
  44. 7.8.1 Somnus Therapeutics Company Information
  45. 7.8.2 Somnus Therapeutics Business Overview
  46. 7.8.3 Somnus Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Somnus Therapeutics Insomnia Medication Product Portfolio
  48. 7.8.5 Somnus Therapeutics Recent Developments
  49. 7.9 SkyePharma
  50. 7.9.1 SkyePharma Company Information
  51. 7.9.2 SkyePharma Business Overview
  52. 7.9.3 SkyePharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 SkyePharma Insomnia Medication Product Portfolio
  54. 7.9.5 SkyePharma Recent Developments
  55. 7.10 Purdue Pharma
  56. 7.10.1 Purdue Pharma Company Information
  57. 7.10.2 Purdue Pharma Business Overview
  58. 7.10.3 Purdue Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Purdue Pharma Insomnia Medication Product Portfolio
  60. 7.10.5 Purdue Pharma Recent Developments
  61. 7.11 Pernix Therapeutics
  62. 7.11.1 Pernix Therapeutics Company Information
  63. 7.11.2 Pernix Therapeutics Business Overview
  64. 7.11.3 Pernix Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pernix Therapeutics Insomnia Medication Product Portfolio
  66. 7.11.5 Pernix Therapeutics Recent Developments
  67. 7.12 Paratek Pharmaceuticals
  68. 7.12.1 Paratek Pharmaceuticals Company Information
  69. 7.12.2 Paratek Pharmaceuticals Business Overview
  70. 7.12.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Paratek Pharmaceuticals Insomnia Medication Product Portfolio
  72. 7.12.5 Paratek Pharmaceuticals Recent Developments
  73. 7.13 Neurim
  74. 7.13.1 Neurim Company Information
  75. 7.13.2 Neurim Business Overview
  76. 7.13.3 Neurim Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Neurim Insomnia Medication Product Portfolio
  78. 7.13.5 Neurim Recent Developments
  79. 7.14 Minerva Neurosciences
  80. 7.14.1 Minerva Neurosciences Company Information
  81. 7.14.2 Minerva Neurosciences Business Overview
  82. 7.14.3 Minerva Neurosciences Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Minerva Neurosciences Insomnia Medication Product Portfolio
  84. 7.14.5 Minerva Neurosciences Recent Developments
  85. 7.15 Meda
  86. 7.15.1 Meda Company Information
  87. 7.15.2 Meda Business Overview
  88. 7.15.3 Meda Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Meda Insomnia Medication Product Portfolio
  90. 7.15.5 Meda Recent Developments
  91. 7.16 Flynn Pharma
  92. 7.16.1 Flynn Pharma Company Information
  93. 7.16.2 Flynn Pharma Business Overview
  94. 7.16.3 Flynn Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Flynn Pharma Insomnia Medication Product Portfolio
  96. 7.16.5 Flynn Pharma Recent Developments
  97. 7.17 ECR Pharmaceuticals (Valeant)
  98. 7.17.1 ECR Pharmaceuticals (Valeant) Company Information
  99. 7.17.2 ECR Pharmaceuticals (Valeant) Business Overview
  100. 7.17.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio
  102. 7.17.5 ECR Pharmaceuticals (Valeant) Recent Developments
  103. 7.18 Dainippon Sumitomo
  104. 7.18.1 Dainippon Sumitomo Company Information
  105. 7.18.2 Dainippon Sumitomo Business Overview
  106. 7.18.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Dainippon Sumitomo Insomnia Medication Product Portfolio
  108. 7.18.5 Dainippon Sumitomo Recent Developments
  109. 7.19 Astellas
  110. 7.19.1 Astellas Company Information
  111. 7.19.2 Astellas Business Overview
  112. 7.19.3 Astellas Insomnia Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Astellas Insomnia Medication Product Portfolio
  114. 7.19.5 Astellas Recent Developments
8 North America
  1. 8.1 North America Insomnia Medication Market Size by Type
  2. 8.1.1 North America Insomnia Medication Revenue by Type (2021-2032)
  3. 8.1.2 North America Insomnia Medication Sales by Type (2021-2032)
  4. 8.1.3 North America Insomnia Medication Price by Type (2021-2032)
  5. 8.2 North America Insomnia Medication Market Size by Application
  6. 8.2.1 North America Insomnia Medication Revenue by Application (2021-2032)
  7. 8.2.2 North America Insomnia Medication Sales by Application (2021-2032)
  8. 8.2.3 North America Insomnia Medication Price by Application (2021-2032)
  9. 8.3 North America Insomnia Medication Market Size by Country
  10. 8.3.1 North America Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Insomnia Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Insomnia Medication Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Insomnia Medication Market Size by Type
  2. 9.1.1 Europe Insomnia Medication Revenue by Type (2021-2032)
  3. 9.1.2 Europe Insomnia Medication Sales by Type (2021-2032)
  4. 9.1.3 Europe Insomnia Medication Price by Type (2021-2032)
  5. 9.2 Europe Insomnia Medication Market Size by Application
  6. 9.2.1 Europe Insomnia Medication Revenue by Application (2021-2032)
  7. 9.2.2 Europe Insomnia Medication Sales by Application (2021-2032)
  8. 9.2.3 Europe Insomnia Medication Price by Application (2021-2032)
  9. 9.3 Europe Insomnia Medication Market Size by Country
  10. 9.3.1 Europe Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Insomnia Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Insomnia Medication Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Insomnia Medication Market Size by Type
  2. 10.1.1 China Insomnia Medication Revenue by Type (2021-2032)
  3. 10.1.2 China Insomnia Medication Sales by Type (2021-2032)
  4. 10.1.3 China Insomnia Medication Price by Type (2021-2032)
  5. 10.2 China Insomnia Medication Market Size by Application
  6. 10.2.1 China Insomnia Medication Revenue by Application (2021-2032)
  7. 10.2.2 China Insomnia Medication Sales by Application (2021-2032)
  8. 10.2.3 China Insomnia Medication Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Insomnia Medication Market Size by Type
  2. 11.1.1 Asia Insomnia Medication Revenue by Type (2021-2032)
  3. 11.1.2 Asia Insomnia Medication Sales by Type (2021-2032)
  4. 11.1.3 Asia Insomnia Medication Price by Type (2021-2032)
  5. 11.2 Asia Insomnia Medication Market Size by Application
  6. 11.2.1 Asia Insomnia Medication Revenue by Application (2021-2032)
  7. 11.2.2 Asia Insomnia Medication Sales by Application (2021-2032)
  8. 11.2.3 Asia Insomnia Medication Price by Application (2021-2032)
  9. 11.3 Asia Insomnia Medication Market Size by Country
  10. 11.3.1 Asia Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Insomnia Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Insomnia Medication Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Insomnia Medication Market Size by Type
  2. 12.1.1 SAMEA Insomnia Medication Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Insomnia Medication Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Insomnia Medication Price by Type (2021-2032)
  5. 12.2 SAMEA Insomnia Medication Market Size by Application
  6. 12.2.1 SAMEA Insomnia Medication Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Insomnia Medication Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Insomnia Medication Price by Application (2021-2032)
  9. 12.3 SAMEA Insomnia Medication Market Size by Country
  10. 12.3.1 SAMEA Insomnia Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Insomnia Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Insomnia Medication Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Insomnia Medication Value Chain Analysis
  2. 13.1.1 Insomnia Medication Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Insomnia Medication Production Mode & Process
  6. 13.2 Insomnia Medication Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Insomnia Medication Distributors
  9. 13.2.3 Insomnia Medication Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst